Nilotinib and allogeneic stem cell transplantation in a chronic myeloid leukemia patient with e6a2 and e1a2 BCR-ABL transcripts

Leuk Res. 2010 Aug;34(8):e204-5. doi: 10.1016/j.leukres.2010.02.022. Epub 2010 Mar 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Combined Modality Therapy
  • Exons / genetics*
  • Fusion Proteins, bcr-abl / genetics*
  • Fusion Proteins, bcr-abl / metabolism
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Male
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / therapeutic use*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stem Cell Transplantation*
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Pyrimidines
  • RNA, Messenger
  • Protein-Tyrosine Kinases
  • Fusion Proteins, bcr-abl
  • nilotinib